KYBELLA Patient Before and After (Front view)

KYBELLA™ is a prescription medicine used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called “double chin.”

KYBELLA Patient Before and After (Side view)

KYBELLA™ Frequently Asked Questions

Can KYBELLA™ be used to eliminate fat in other areas of the body? Is it a potential treatment for obesity or alternative to liposuction?
KYBELLA™ is only indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. The safe and effective use of KYBELLA™ for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.

Is KYTHERA seeking other indications or for larger quantities to be injected?
KYTHERA is not currently seeking other indications for KYBELLA™ at this time.

What is the recommended dosage for KYBELLA™?

What are the side effects? For example, do patients need to worry about nerve injury?

How many injections/treatments does a patient need?

How safe is KYBELLA™?

Are any long-term safety studies planned?
Yes. Several long-term follow-up studies have already been completed or are ongoing as part of the clinical program and have documented consistent and long-lasting improvements in SMF.

Is KYTHERA planning any post-approval or registry studies?
The majority of patients only need one treatment; however, some may benefit from more than one treatment depending on how much laxity they have and their body’s own biological response to the ultrasound and the collagen-building process. KYTHERA is planning to conduct a prospective, observational, multicenter registry study called CONTOUR to develop a better understanding of the condition of submental fullness, how it is treated in current clinical practice, and risks and benefits associated with its treatment. This registry will involve the systemic collection of data on:

What is the recovery like with KYBELLA™ compared to liposuction? Can I return to work the same day?

Are there any competitors to KYBELLA™?
KYBELLA™ (deoxycholic acid) injection is the first and only FDA-approved injectable drug that contours and improves the appearance of submental fullness due to submental fat.

Is this like BOTOX where you need to keep going back for treatment? Will the fat come back in other parts of the body?
To date, there have been no comparative studies between KYBELLA™ and BOTOX. When injected into subcutaneous fat over a single series of treatments (no more than 6), KYBELLA™ causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat.

Who is not a good candidate for KYBELLA™?

Will insurance cover it?
No, like most injectables for aesthetic benefit, insurance does not cover KYBELLA™ for the treatment of submental fullness due to submental fat.